Current therapy for CLL and the new monoclonal antibody ofatumumab
The differences in treating older versus younger CLL patients
An update on immunotherapy for multiple myeloma in 2016
Ignacio Melero Bermejo et al.
The basis for immunotherapy in multiple myeloma
Ignacio Melero Bermejo
Preliminary results of the AIM trial of ibrutinib and venetoclax in mantle cell lymphoma